TP53 and acute myeloid leukemia: Results of a multivariate Cox regression analysis of the Singhal study showed that T-AML, high revised International Prognostic Scoring System cytogenetic category, TP53 variant, and NRAS variant were independent aggressive factors, however, treatment with disease-modifying therapy resulted in better OS.